Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 7 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Moderna's RSV vaccine for older adults approved
Axios· 7 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoThe cancer vaccine reduced the likelihood cancer would return or patients would die by 49% after...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 12 minutes agoThe company also unveiled promising results in...Pfizer is competing against GSK's Arexvy, which hit...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 7 days agoThe FDA has approved Moderna's RSV vaccine for older adults. The Food and Drug Administration on...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 7 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair...recipients of...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe conversation with your doctor should include whether the vaccine is appropriate for you, and if...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days agoOn March 31, it had $12.2 billion in cash and investments, or $1.1 billion less than it had a year...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 3 days agoThat breaks my heart." One hope, he said, is that researchers will be able to identify a limited...